FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4287149037> ?p ?o ?g. }

• W4287149037 endingPage "4676" @default.
• W4287149037 startingPage "4676" @default.
• W4287149037 abstract "The adenosine A2A receptor (A2AAR) is a class A G-protein-coupled receptor (GPCR). It is an immune checkpoint in the tumor micro-environment and has become an emerging target for cancer treatment. In this study, we aimed to explore the effects of cancer-patient-derived A2AAR mutations on ligand binding and receptor functions. The wild-type A2AAR and 15 mutants identified by Genomic Data Commons (GDC) in human cancers were expressed in HEK293T cells. Firstly, we found that the binding affinity for agonist NECA was decreased in six mutants but increased for the V275A mutant. Mutations A165V and A265V decreased the binding affinity for antagonist ZM241385. Secondly, we found that the potency of NECA (EC50) in an impedance-based cell-morphology assay was mostly correlated with the binding affinity for the different mutants. Moreover, S132L and H278N were found to shift the A2AAR towards the inactive state. Importantly, we found that ZM241385 could not inhibit the activation of V275A and P285L stimulated by NECA. Taken together, the cancer-associated mutations of A2AAR modulated ligand binding and receptor functions. This study provides fundamental insights into the structure-activity relationship of the A2AAR and provides insights for A2AAR-related personalized treatment in cancer." @default.
• W4287149037 created "2022-07-25" @default.
• W4287149037 creator A5000466768 @default.
• W4287149037 creator A5001540053 @default.
• W4287149037 creator A5032891478 @default.
• W4287149037 creator A5034098867 @default.
• W4287149037 creator A5037747325 @default.
• W4287149037 creator A5041475295 @default.
• W4287149037 creator A5063810062 @default.
• W4287149037 creator A5079313226 @default.
• W4287149037 creator A5088996741 @default.
• W4287149037 date "2022-07-22" @default.
• W4287149037 modified "2023-10-01" @default.
• W4287149037 title "Cancer-Associated Mutations of the Adenosine A2A Receptor Have Diverse Influences on Ligand Binding and Receptor Functions" @default.
• W4287149037 cites W1497573731 @default.
• W4287149037 cites W1675343160 @default.
• W4287149037 cites W1959100396 @default.
• W4287149037 cites W1963952222 @default.
• W4287149037 cites W1965132832 @default.
• W4287149037 cites W1969591740 @default.
• W4287149037 cites W1975740938 @default.
• W4287149037 cites W1976543220 @default.
• W4287149037 cites W1977417864 @default.
• W4287149037 cites W1979019662 @default.
• W4287149037 cites W1980760876 @default.
• W4287149037 cites W1981552113 @default.
• W4287149037 cites W1989969172 @default.
• W4287149037 cites W2030272844 @default.
• W4287149037 cites W2038709562 @default.
• W4287149037 cites W2038809815 @default.
• W4287149037 cites W2039399096 @default.
• W4287149037 cites W2059594639 @default.
• W4287149037 cites W2066482395 @default.
• W4287149037 cites W2074631079 @default.
• W4287149037 cites W2077703512 @default.
• W4287149037 cites W2084443657 @default.
• W4287149037 cites W2085381168 @default.
• W4287149037 cites W2092166752 @default.
• W4287149037 cites W2102513649 @default.
• W4287149037 cites W2104549677 @default.
• W4287149037 cites W2106861254 @default.
• W4287149037 cites W2109254532 @default.
• W4287149037 cites W2120426523 @default.
• W4287149037 cites W2124374905 @default.
• W4287149037 cites W2128588800 @default.
• W4287149037 cites W2131783439 @default.
• W4287149037 cites W2155547273 @default.
• W4287149037 cites W2273675903 @default.
• W4287149037 cites W2280969907 @default.
• W4287149037 cites W2439566903 @default.
• W4287149037 cites W2499343687 @default.
• W4287149037 cites W2519184848 @default.
• W4287149037 cites W2521492299 @default.
• W4287149037 cites W2623410148 @default.
• W4287149037 cites W2774484667 @default.
• W4287149037 cites W2775177930 @default.
• W4287149037 cites W2775184670 @default.
• W4287149037 cites W2802868810 @default.
• W4287149037 cites W2896900849 @default.
• W4287149037 cites W2921670360 @default.
• W4287149037 cites W2948545594 @default.
• W4287149037 cites W3030533699 @default.
• W4287149037 cites W3110608978 @default.
• W4287149037 cites W3210057495 @default.
• W4287149037 cites W3216978478 @default.
• W4287149037 cites W4232534952 @default.
• W4287149037 doi "https://doi.org/10.3390/molecules27154676" @default.
• W4287149037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35897852" @default.
• W4287149037 hasPublicationYear "2022" @default.
• W4287149037 type Work @default.
• W4287149037 citedByCount "2" @default.
• W4287149037 countsByYear W42871490372023 @default.
• W4287149037 crossrefType "journal-article" @default.
• W4287149037 hasAuthorship W4287149037A5000466768 @default.
• W4287149037 hasAuthorship W4287149037A5001540053 @default.
• W4287149037 hasAuthorship W4287149037A5032891478 @default.
• W4287149037 hasAuthorship W4287149037A5034098867 @default.
• W4287149037 hasAuthorship W4287149037A5037747325 @default.
• W4287149037 hasAuthorship W4287149037A5041475295 @default.
• W4287149037 hasAuthorship W4287149037A5063810062 @default.
• W4287149037 hasAuthorship W4287149037A5079313226 @default.
• W4287149037 hasAuthorship W4287149037A5088996741 @default.
• W4287149037 hasBestOaLocation W42871490371 @default.
• W4287149037 hasConcept C104317684 @default.
• W4287149037 hasConcept C116569031 @default.
• W4287149037 hasConcept C121608353 @default.
• W4287149037 hasConcept C135285700 @default.
• W4287149037 hasConcept C143065580 @default.
• W4287149037 hasConcept C153911025 @default.
• W4287149037 hasConcept C170493617 @default.
• W4287149037 hasConcept C174510640 @default.
• W4287149037 hasConcept C2778938600 @default.
• W4287149037 hasConcept C502942594 @default.
• W4287149037 hasConcept C54355233 @default.
• W4287149037 hasConcept C55493867 @default.
• W4287149037 hasConcept C67907053 @default.
• W4287149037 hasConcept C86803240 @default.
• W4287149037 hasConcept C95444343 @default.

• next